Sunday, September 27, 2015

Dirk Hausseckar tweets Sangamo Related Info

  1. 6 hours ago
    key competitive technological advantage: obligate heterodimers for impressive targeting specificity.
    1 favorite
  2. 10 hours ago
    PCSK9, CC5 etc..monoclonal antibody apologists say 100% inhibition by MAbs, 90-98% by RNAi. Well, MAb that's just for few days.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)